TRANSLATIONAL INDEX
Live / Registered — Registered (as of 10 Sept 2024)
What this means for you
Registered since 10 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97882540
- Registration number
- 7504463
- Mark type
- Stylized text
- Filed
- 11 Apr 2023
- Registered
- 10 Sept 2024
- Attorney of record
- Norm J. Rich
Goods and services
- Class 044 — Medical, beauty and agricultural services: Software as a service (SAAS) services featuring software for modeling, rating, scoring and reporting on the conducting of simulations and predictions of properties of drugs or chemicals or vaccines including absorption, release rate, bioavailability, pharmacokinetics and pharmacodynamics, safety, toxicology, and efficacy profiles, routes of administration, and dose optimization; Software as a service (SAAS) services featuring software that allows for the simulation, prediction, rating, scoring, and reporting of drug-to-drug interactions; Software as a service (SAAS) services featuring software for the simulation, prediction, rating, scoring, and reporting of drug or vaccines or chemical effects on animals and virtual animal or patient populations; Software as a service (SAAS) services featuring software which allows researchers to adjust pharmacodynamic models to observed data and to then use the resulting fitted models to simulate, predict, rate, score, and report on pharmacodynamic changes due to changes in routes of administration, dose, dosage form, and dosing regimen of a drug or chemical or vaccine; Software as a service (SAAS) services featuring software which allow for the prediction, rating, scoring, and reporting of absorption and systemic distribution/elimination for large molecules; Software as a service (SAAS) services featuring software that incorporates artificial intelligence and machine learning to simulate, predict, rate, score, and report on the clinical efficacy of new drugs or chemicals or or vaccines before human trials and accelerate pharmaceutical drug or vaccine development and regulatory approval
Owner
- VeriSIM Life Inc., San Francisco, CA, US
- VeriSIM Life Inc., San Francisco, CA, US
Prosecution history
- 10 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Sept 2024 — REGISTERED-SUPPLEMENTAL REGISTER
- 02 Aug 2024 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 02 Aug 2024 — EXAMINER'S AMENDMENT ENTERED
- 02 Aug 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 02 Aug 2024 — EXAMINERS AMENDMENT E-MAILED
- 02 Aug 2024 — EXAMINERS AMENDMENT -WRITTEN
- 02 Aug 2024 — USE AMENDMENT ACCEPTED
- 30 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Jul 2024 — ASSIGNED TO LIE
- 09 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Feb 2024 — AMENDMENT TO USE PROCESSING COMPLETE
- 08 Feb 2024 — USE AMENDMENT FILED
- 08 Feb 2024 — TEAS AMENDMENT OF USE RECEIVED